EE87 Economic Evauation of Adalimumab Biosimilars and JAK Inhibitors for the Treatment of Moderate-to-Severe Rheumatoid Arthritis
| Autor: | Rickard, I, Carmona, E, Lessing, T, Furrer, M, Keady, S |
|---|---|
| Zdroj: | In Value in Health July 2022 25(7) Supplement:S351-S351 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect